Test Price
2,800 AED✅ Home Collection Available
DSP Gene (Skin Fragility-Woolly Hair Syndrome) Genetic Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
- ✓ Diagnostic Accuracy: 99.9% sensitivity using massively parallel NGS at an ISO 9001:2015 certified laboratory.
- ✓ VIP Mobile Phlebotomy & Cold-Chain Home Collection: Available daily from 8 AM to 11 PM across Dubai and the Northern Emirates.
- ✓ Post-Test Genetic Counseling: Telephone consultation with a specialist to interpret your report and outline management steps.
- ✓ Insurance Verification: Confirm coverage via WhatsApp +971 54 548 8731 – accepted by all major insurers.
Test Overview & Methodology
This NGS-based genetic test sequences the entire DSP gene to definitively diagnose skin fragility-woolly hair syndrome, a rare ectodermal dysplasia with significant cardiac implications. Performed under DHA regulatory standards, the test provides dermatologists and clinical geneticists with actionable data for patient management, including surveillance for arrhythmogenic cardiomyopathy.
| Feature | DNA Labs UAE – NGS | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Technology | Massively Parallel NGS – Full DSP gene coverage | Targeted single-exon sequencing |
| Diagnostic Sensitivity | 99.9% (detects all variant types, including deep intronic) | ~85% for point mutations only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Accreditation | ISO 9001:2015 & DHA Facility License 1143 | Varies by laboratory |
| Price | 2,800 AED | 2,200–3,500 AED |
Physician Insight & Safety Protocols
“A positive DSP mutation confirms the clinical diagnosis but must be interpreted alongside the full phenotype — particularly a cardiology assessment for arrhythmogenic cardiomyopathy. This test is one component of a comprehensive workup; never rely on genetic data in isolation. Our reports are clinically correlated and include actionable recommendations for the managing physician.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory Notice
Do not discontinue any prescribed medication or modify your treatment regimen based solely on this genetic result without direct consultation with your treating physician. Genetic findings require clinical correlation and should never replace professional medical advice.
Exclusion Criteria & Red Flags
- Recent blood transfusion or bone marrow transplant (may interfere with DNA source).
- Uncontrolled bleeding disorder — consult your physician before sample collection.
- Minors: Genetic testing requires explicit consent from a legal guardian and pre-test genetic counseling as per UAE regulatory frameworks.
- Emergency Red Flags: If you experience sudden chest pain, fainting episodes, or severe palpitations before or after testing, seek immediate emergency care — these may indicate cardiac involvement in DSP-related syndromes.
Patient FAQ & Clinical Guidance
1. What exactly does this test detect?
This test sequences the entire DSP gene to identify mutations linked to skin fragility, woolly hair, and potentially life-threatening cardiomyopathy. NGS technology enables high-resolution detection of single nucleotide variants, insertions/deletions, and copy number abnormalities that conventional methods often miss.
2. Who should consider undergoing this genetic test?
Individuals with suggestive skin and hair abnormalities, a family history of the condition, or unexplained cardiomyopathy should pursue testing alongside genetic counseling. Early diagnosis guides surveillance for cardiac complications and informs family planning — pediatric patients particularly benefit from early monitoring.
3. How is the sample collected and what is the turnaround time?
A simple blood draw or DNA sample is collected by a certified phlebotomist at your home or in our facility within 24 hours of booking. Results are available in 3–4 weeks. The home visit follows temperature-controlled cold-chain protocols, and the entire process is conducted under DHA Facility License 1143.
4. What are the cardiac implications of a DSP mutation?
Mutations in the DSP gene are associated with arrhythmogenic cardiomyopathy, a condition that can lead to heart rhythm abnormalities and sudden cardiac arrest. A positive genetic result warrants a thorough cardiology evaluation, including ECG, echocardiogram, and possibly Holter monitoring, even in the absence of symptoms.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
DHA Facility License: 1143 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Corporate Lab: DNA Labs UAE | WhatsApp: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | DSP Gene (Skin Fragility-Woolly Hair Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood / DNA (Peripheral Venipuncture or FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Q84.2, Q82.8 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians